Phase 2CompletedAge-related condition

A Biomarker Study of ATH434 in Participants With MSA

An Open-Label Biomarker Study of ATH434 in Multiple System Atrophy

Sponsor
Alterity Therapeutics (Industry)
Enrollment
10 enrolled
Conditions
Multiple System Atrophy
Interventions
ATH434
Ages
adults, older adults
Registry
NCT05864365

Full record on ClinicalTrials.gov

From the registry

This study will assess the safety and efficacy of ATH434 in participants with a clinical diagnosis of Multiple System Atrophy

Primary outcomes

  • Change in brain volume as measured by MRI

History

  1. Last registry update

  2. Primary completion

  3. Started

  4. Registered